135 related articles for article (PubMed ID: 19941986)
1. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector.
Kim DS; Cho YJ; Kim BG; Lee SH; Nam JH
Vaccine; 2010 Feb; 28(5):1234-40. PubMed ID: 19941986
[TBL] [Abstract][Full Text] [Related]
2. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
Siler CA; McGettigan JP; Dietzschold B; Herrine SK; Dubuisson J; Pomerantz RJ; Schnell MJ
Virology; 2002 Jan; 292(1):24-34. PubMed ID: 11878905
[TBL] [Abstract][Full Text] [Related]
3. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
[TBL] [Abstract][Full Text] [Related]
5. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
[TBL] [Abstract][Full Text] [Related]
6. Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene.
Sominskaya I; Alekseeva E; Skrastina D; Mokhonov V; Starodubova E; Jansons J; Levi M; Prilipov A; Kozlovska T; Smirnov V; Pumpens P; Isaguliants MG
Mol Immunol; 2006 May; 43(12):1941-52. PubMed ID: 16442623
[TBL] [Abstract][Full Text] [Related]
7. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
[TBL] [Abstract][Full Text] [Related]
8. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
[TBL] [Abstract][Full Text] [Related]
9. [Expression and immune response to hepatitis C virus core gene combined hepatitis B virus core gene with two multiple cloning sites vector].
Deng T; Fan G; Chen T; Chen N; Hu D; Wang M; Jia K
Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):77-80. PubMed ID: 11953132
[TBL] [Abstract][Full Text] [Related]
10. Effect of immunization in mice with recombinant DNA encoding the hepatitis C virus structural protein.
Dou J; Liu K; Chen Z; Wo J; He N; Liu Y; Zhang M; Wang X; Xu C
Chin Med J (Engl); 1999 Nov; 112(11):1036-9. PubMed ID: 11721468
[TBL] [Abstract][Full Text] [Related]
11. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
12. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
13. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
Kamei A; Tamaki S; Taniyama H; Takamura S; Nishimura Y; Kagawa Y; Uno-Furuta S; Kaito M; Kim G; Toda M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
Virology; 2000 Jul; 273(1):120-6. PubMed ID: 10891414
[TBL] [Abstract][Full Text] [Related]
14. [Induction of antibody to hepatitis C virus E2 antigene can be enhanced by coinjection of interleukin-2 and HCV E2 expression plasmid].
Ma W; Feng B
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):383-5. PubMed ID: 11798791
[TBL] [Abstract][Full Text] [Related]
15. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
Vidalin O; Fournillier A; Renard N; Chen M; Depla E; Boucreux D; Brinster C; Baumert T; Nakano I; Fukuda Y; Liljeström P; Trépo C; Inchauspé G
Virology; 2000 Oct; 276(2):259-70. PubMed ID: 11040118
[TBL] [Abstract][Full Text] [Related]
16. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
[TBL] [Abstract][Full Text] [Related]
17. Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
Liu M; Chen H; Luo F; Li P; Pan Q; Xia B; Qi Z; Ho WZ; Zhang XL
Vaccine; 2007 Sep; 25(36):6572-80. PubMed ID: 17675185
[TBL] [Abstract][Full Text] [Related]
18. Ratio of HCV structural antigens in protein-based vaccine formulations is critical for functional immune response induction.
Martínez-Donato G; Musacchio A; Alvarez-Lajonchere L; Acosta-Rivero N; Amador Y; Guerra I; Peña D; Pérez A; Castro J; Puentes P; Soria Y; Cosme K; Sanchez J; Dueñas-Carrera S
Biotechnol Appl Biochem; 2010 Jul; 56(3):111-8. PubMed ID: 20515441
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins.
Abraham JD; Himoudi N; Kien F; Berland JL; Codran A; Bartosch B; Baumert T; Paranhos-Baccala G; Schuster C; Inchauspé G; Kieny MP
Vaccine; 2004 Sep; 22(29-30):3917-28. PubMed ID: 15364440
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast.
Cai W; Su L; Liao Q; Ye L; Wu Y; Wu Z; She Y
Antiviral Res; 2010 Oct; 88(1):80-5. PubMed ID: 20691736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
